22.05.2017
- US life science company Cambrex is adding a fourth reactor suite at its site in High Point, North Carolina, expanding pilot plant capabilities to meet rising demand. The investment...
11.01.2017
- Cambrex has named Tom Vadaketh executive vice president and CFO, effective Jan. 20, 2017. Greg Sargen, current CFO at Cambrex, will transition to a newly-created role, EVP...
12.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
12.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
06.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
05.10.2016
- US life sciences company Cambrex has completed and validated a new pilot plant at its manufacturing and R&D site in Paullo, Milan, Italy. Built to meet customer demand for small...
27.09.2016
- In a move to boost its portfolio of small molecule API services, US-based life sciences company Cambrex has agreed to buy PharmaCore for $25 million. With 60 employees, PharmaCore...
16.09.2016
- Cambrex, the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), has announced a SEK 72 million ($9 million) investment to expand...
